RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 93 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,829,000 | -2.6% | 1,550,204 | -6.6% | 0.00% | – |
Q2 2022 | $1,877,000 | -62.2% | 1,660,402 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $4,965,000 | +17.7% | 1,660,402 | +4.3% | 0.00% | 0.0% |
Q4 2021 | $4,217,000 | -17.4% | 1,591,192 | +13.2% | 0.00% | 0.0% |
Q3 2021 | $5,105,000 | -83.3% | 1,406,200 | -80.0% | 0.00% | -80.0% |
Q2 2021 | $30,582,000 | +44.0% | 7,046,570 | +13.5% | 0.01% | +25.0% |
Q1 2021 | $21,242,000 | -45.8% | 6,211,072 | -44.5% | 0.00% | -42.9% |
Q4 2020 | $39,195,000 | +19.0% | 11,198,571 | -18.4% | 0.01% | 0.0% |
Q3 2020 | $32,928,000 | +15.2% | 13,719,993 | -12.2% | 0.01% | +16.7% |
Q2 2020 | $28,587,000 | +16.7% | 15,621,191 | -0.6% | 0.01% | 0.0% |
Q1 2020 | $24,506,000 | -31.9% | 15,709,067 | -6.5% | 0.01% | -25.0% |
Q4 2019 | $35,968,000 | -12.6% | 16,807,261 | -23.6% | 0.01% | -11.1% |
Q3 2019 | $41,137,000 | -32.4% | 21,998,116 | -5.6% | 0.01% | -30.8% |
Q2 2019 | $60,843,000 | +1.2% | 23,311,375 | -0.3% | 0.01% | -7.1% |
Q1 2019 | $60,109,000 | +12.0% | 23,388,484 | +0.3% | 0.01% | +7.7% |
Q4 2018 | $53,656,000 | -28.2% | 23,328,436 | +0.2% | 0.01% | -18.8% |
Q3 2018 | $74,743,000 | +17.5% | 23,284,515 | +3.6% | 0.02% | +14.3% |
Q2 2018 | $63,630,000 | -12.8% | 22,483,640 | +9.1% | 0.01% | -17.6% |
Q1 2018 | $72,965,000 | -7.3% | 20,611,455 | +1.6% | 0.02% | 0.0% |
Q4 2017 | $78,745,000 | +105.8% | 20,295,036 | +34.7% | 0.02% | +88.9% |
Q3 2017 | $38,261,000 | -1.0% | 15,063,236 | +6.4% | 0.01% | 0.0% |
Q2 2017 | $38,635,000 | -15.7% | 14,152,051 | +2.2% | 0.01% | -18.2% |
Q1 2017 | $45,823,000 | +82.3% | 13,843,629 | +31.1% | 0.01% | +83.3% |
Q4 2016 | $25,135,000 | +42.2% | 10,561,239 | +119.3% | 0.01% | +50.0% |
Q3 2016 | $17,675,000 | +55.0% | 4,816,349 | -5.8% | 0.00% | +33.3% |
Q2 2016 | $11,405,000 | +7.5% | 5,114,176 | +0.3% | 0.00% | 0.0% |
Q1 2016 | $10,607,000 | -42.4% | 5,099,534 | -16.2% | 0.00% | -40.0% |
Q4 2015 | $18,429,000 | +27.2% | 6,082,344 | +3.7% | 0.01% | +25.0% |
Q3 2015 | $14,493,000 | -9.6% | 5,867,694 | +17.4% | 0.00% | 0.0% |
Q2 2015 | $16,040,000 | -8.7% | 4,996,564 | +1.5% | 0.00% | -20.0% |
Q1 2015 | $17,575,000 | +57.5% | 4,923,234 | +0.1% | 0.01% | +66.7% |
Q4 2014 | $11,162,000 | +16.5% | 4,916,925 | -0.5% | 0.00% | 0.0% |
Q3 2014 | $9,582,000 | -57.1% | 4,939,410 | -19.8% | 0.00% | -50.0% |
Q2 2014 | $22,349,000 | +28.7% | 6,156,658 | +37.6% | 0.01% | +20.0% |
Q1 2014 | $17,362,000 | +34.3% | 4,474,598 | -1.4% | 0.01% | +25.0% |
Q4 2013 | $12,931,000 | -32.6% | 4,537,178 | -15.3% | 0.00% | -33.3% |
Q3 2013 | $19,184,000 | -37.2% | 5,358,678 | -41.4% | 0.01% | -40.0% |
Q2 2013 | $30,551,000 | – | 9,147,099 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |